Diabetes, scientifically known as diabetes mellitus, is a clinical condition where person has an elevated blood glucose level.
Scope of the Report:
This report studies the Diabetes Management market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Diabetes Management market by product type and applications/end industries.
It occurs due to either inefficiency of pancreases to produce insulin (Type I) or unresponsiveness of body cells to the produced insulin (Type II) or both. This condition specifically results in polyuria, increase in thrust and hunger. This condition specifically results in polyuria, increase in thrust and hunger.
The global Diabetes Management market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Diabetes Management.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott
Bayer
Bristol-Myers Squibb
Eli Lilly
Sanofi
Dexcom
Medtronic
Novo Nordisk
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
Market Segment by Applications, can be divided into
Hospital
home
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Diabetes Management Market Overview
1.1 Product Overview and Scope of Diabetes Management
1.2 Classification of Diabetes Management by Types
1.2.1 Global Diabetes Management Revenue Comparison by Types (2017-2023)
1.2.2 Global Diabetes Management Revenue Market Share by Types in 2017
1.2.3 Monitoring Devices
1.2.4 Diagnostic Devices
1.2.5 Insulin Delivery Devices
1.2.6 Other Devices
1.3 Global Diabetes Management Market by Application
1.3.1 Global Diabetes Management Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 home
1.4 Global Diabetes Management Market by Regions
1.4.1 Global Diabetes Management Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Diabetes Management Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Diabetes Management Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diabetes Management Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Diabetes Management Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diabetes Management Status and Prospect (2013-2023)
1.5 Global Market Size of Diabetes Management (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Diabetes Management Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Diabetes Management Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Diabetes Management Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Diabetes Management Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol-Myers Squibb
2.3.1 Business Overview
2.3.2 Diabetes Management Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol-Myers Squibb Diabetes Management Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Diabetes Management Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Diabetes Management Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Diabetes Management Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Diabetes Management Revenue, Gross Margin and Market Share (2016-2017)
2.6 Dexcom
2.6.1 Business Overview
2.6.2 Diabetes Management Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dexcom Diabetes Management Revenue, Gross Margin and Market Share (2016-2017)
2.7 Medtronic
2.7.1 Business Overview
2.7.2 Diabetes Management Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Medtronic Diabetes Management Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novo Nordisk
2.8.1 Business Overview
2.8.2 Diabetes Management Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novo Nordisk Diabetes Management Revenue, Gross Margin and Market Share (2016-2017)
3 Global Diabetes Management Market Competition, by Players
3.1 Global Diabetes Management Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Diabetes Management Players Market Share
3.2.2 Top 10 Diabetes Management Players Market Share
3.3 Market Competition Trend
4 Global Diabetes Management Market Size by Regions
4.1 Global Diabetes Management Revenue and Market Share by Regions
4.2 North America Diabetes Management Revenue and Growth Rate (2013-2018)
4.3 Europe Diabetes Management Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Diabetes Management Revenue and Growth Rate (2013-2018)
4.5 South America Diabetes Management Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Diabetes Management Revenue and Growth Rate (2013-2018)
5 North America Diabetes Management Revenue by Countries
5.1 North America Diabetes Management Revenue by Countries (2013-2018)
5.2 USA Diabetes Management Revenue and Growth Rate (2013-2018)
5.3 Canada Diabetes Management Revenue and Growth Rate (2013-2018)
5.4 Mexico Diabetes Management Revenue and Growth Rate (2013-2018)
6 Europe Diabetes Management Revenue by Countries
6.1 Europe Diabetes Management Revenue by Countries (2013-2018)
6.2 Germany Diabetes Management Revenue and Growth Rate (2013-2018)
6.3 UK Diabetes Management Revenue and Growth Rate (2013-2018)
6.4 France Diabetes Management Revenue and Growth Rate (2013-2018)
6.5 Russia Diabetes Management Revenue and Growth Rate (2013-2018)
6.6 Italy Diabetes Management Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Diabetes Management Revenue by Countries
7.1 Asia-Pacific Diabetes Management Revenue by Countries (2013-2018)
7.2 China Diabetes Management Revenue and Growth Rate (2013-2018)
7.3 Japan Diabetes Management Revenue and Growth Rate (2013-2018)
7.4 Korea Diabetes Management Revenue and Growth Rate (2013-2018)
7.5 India Diabetes Management Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Diabetes Management Revenue and Growth Rate (2013-2018)
8 South America Diabetes Management Revenue by Countries
8.1 South America Diabetes Management Revenue by Countries (2013-2018)
8.2 Brazil Diabetes Management Revenue and Growth Rate (2013-2018)
8.3 Argentina Diabetes Management Revenue and Growth Rate (2013-2018)
8.4 Colombia Diabetes Management Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Diabetes Management by Countries
9.1 Middle East and Africa Diabetes Management Revenue by Countries (2013-2018)
9.2 Saudi Arabia Diabetes Management Revenue and Growth Rate (2013-2018)
9.3 UAE Diabetes Management Revenue and Growth Rate (2013-2018)
9.4 Egypt Diabetes Management Revenue and Growth Rate (2013-2018)
9.5 Nigeria Diabetes Management Revenue and Growth Rate (2013-2018)
9.6 South Africa Diabetes Management Revenue and Growth Rate (2013-2018)
10 Global Diabetes Management Market Segment by Type
10.1 Global Diabetes Management Revenue and Market Share by Type (2013-2018)
10.2 Global Diabetes Management Market Forecast by Type (2018-2023)
10.3 Monitoring Devices Revenue Growth Rate (2013-2023)
10.4 Diagnostic Devices Revenue Growth Rate (2013-2023)
10.5 Insulin Delivery Devices Revenue Growth Rate (2013-2023)
10.6 Other Devices Revenue Growth Rate (2013-2023)
11 Global Diabetes Management Market Segment by Application
11.1 Global Diabetes Management Revenue Market Share by Application (2013-2018)
11.2 Diabetes Management Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 home Revenue Growth (2013-2018)
12 Global Diabetes Management Market Size Forecast (2018-2023)
12.1 Global Diabetes Management Market Size Forecast (2018-2023)
12.2 Global Diabetes Management Market Forecast by Regions (2018-2023)
12.3 North America Diabetes Management Revenue Market Forecast (2018-2023)
12.4 Europe Diabetes Management Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Diabetes Management Revenue Market Forecast (2018-2023)
12.6 South America Diabetes Management Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Diabetes Management Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Diabetes Management Picture
Table Product Specifications of Diabetes Management
Table Global Diabetes Management and Revenue (Million USD) Market Split by Product Ty